NASDAQ
8.14USD
+2.77 (+51.52%)
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
4.4M
P/E
—
EPS
—
Beta
-1.30
52W range
2.44-32.55
Day range
7.38–9.99
Open
7.60
Prev close
5.37
Volume
24.5M
Avg volume
1.6M
Dividend
0.00
IPO
2024-01-29
https://www.globenewswire.com/news-release/2026/06/18/3314530/0/en/Autonomix-Announces-Reverse-Stock-Split.html · 6/18/2026-0.30
https://www.globenewswire.com/news-release/2026/04/08/3270123/0/en/Autonomix-Medical-Selected-for-Featured-Abstract-and-Podium-Presentation-of-Long-Term-Pain-Mitigation-in-Pancreatic-Cancer-at-SIR-2026.html · 4/8/2026+0.90
https://www.globenewswire.com/news-release/2026/01/09/3216092/0/en/Autonomix-Showcases-Compelling-PoC-Study-Clinical-Data-Showing-Rapid-and-Durable-Pain-Relief-Across-All-Disease-Stages-of-Pancreatic-Cancer-at-the-2026-ASCO-Gastrointestinal-GI-Can.html · 1/9/2026+1.00
https://www.globenewswire.com/news-release/2025/12/23/3209889/0/en/Autonomix-Medical-Inc-NASDAQ-AMIX-Highlights-Expanding-IP-Portfolio-and-Multi-Indication-Platform-Strategy-in-Virtual-Investor-CEO-Connect-Segment.html · 12/23/2025
https://www.globenewswire.com/news-release/2025/10/16/3167993/0/en/Autonomix-Medical-Inc-to-Highlight-Innovative-Nerve-Sensing-and-Ablation-Platform-at-the-2025-Maxim-Growth-Summit.html · 10/16/2025+0.20
https://www.globenewswire.com/news-release/2025/09/04/3144563/0/en/Autonomix-Medical-Inc-NASDAQ-AMIX-Participates-in-Virtual-Investor-What-This-Means-Segment.html · 9/4/2025+0.80
https://www.globenewswire.com/news-release/2025/09/03/3143610/0/en/Autonomix-Medical-Inc-Demonstrates-Sustained-Pain-Reduction-Quality-of-Life-Gains-and-100-Zero-Opioid-Use-in-Longer-Term-Post-Hoc-Analysis-from-PoC-1-Study.html · 9/3/2025+1.00
Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. The company’s technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. It develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related disorders. Autonomix Medical, Inc. was incorporated in 2014 and is headquartered in The Woodlands, Texas.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
